Age‐related macular degeneration—emerging pathogenetic and therapeutic concepts

Overview of attention for article published in Annals of Medicine, July 2009

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#17 of 1,665)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 30 news outlets
twitter: 3 X users

patent: 20 patents

Readers on

mendeley: 435 Mendeley

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 637 followers.

RT @xinoxan: @telegraft @ISCTglobal 🤔Who?🧐Current strategies for treating AMD involve stem-cell-based RPE products develop in both academua…

@telegraft @ISCTglobal 🤔Who?🧐Current strategies for treating AMD involve stem-cell-based RPE products develop in both academua and industry. 🔗https://t.co/gGHN3fbfUe https://t.co/axqtUnFKtJ

Abstract AMD is characterized by a progressive loss of central vision attributable to degenerative and neovascular changes in the macula, a highly specialized region of the ocular retina responsible for fine visual acuity. https://t.co/YeLIzvICD6

There are no current therapies for the more common ‘dry’ AMD, except for the use of antioxidants that delay progression in 20%–25% of eyes. https://t.co/YeLIzvICD6

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.